Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Finasteride effectively treats male hair loss, improving growth and density.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Dupilumab helps children with alopecia areata regrow hair safely.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

New psoriasis treatments are effective but come with side effects and risks.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Inhalation therapy may repair and protect elastin in the lungs of COPD patients.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A newborn with ichthyosis was successfully treated using specific neonatal care methods.

Polynucleotide-based treatments effectively reduce aging signs and aid tissue recovery.

Dermatophytes, like Trichophyton rubrum, can cause allergies and chronic inflammation.

Expand access to prevention and address barriers for sex workers in Kostanay.

JAK inhibitors are effective for long-term management of alopecia areata.